Core Scientific (Core Scientific) Capex-to-Operating-Cash-Flow : 1.44 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Core Scientific Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Core Scientific's Capital Expenditure for the three months ended in Mar. 2024 was $-31.89 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2024 was $22.17 Mil.

Hence, Core Scientific's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2024 was 1.44.

Core Scientific Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Core Scientific's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Scientific Capex-to-Operating-Cash-Flow Chart

Core Scientific Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Operating-Cash-Flow

2.93

0.26

Core Scientific Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Capex-to-Operating-Cash-Flow	Get a 7-Day Free Trial											0.08	0.05	0.53	0.54	1.44

Competitive Comparison of Core Scientific's Capex-to-Operating-Cash-Flow

For the Software - Infrastructure subindustry, Core Scientific's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Core Scientific's Capex-to-Operating-Cash-Flow Distribution in the Software Industry

For the Software industry and Technology sector, Core Scientific's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Core Scientific's Capex-to-Operating-Cash-Flow falls into.

Core Scientific Capex-to-Operating-Cash-Flow Calculation

Core Scientific's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow	=	- Capital Expenditure	/	Cash Flow from Operations
	=	- (-16.994)	/	65.114
	=	0.26

Core Scientific's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow	=	- Capital Expenditure	/	Cash Flow from Operations
	=	- (-31.894)	/	22.174
	=	1.44

Core Scientific (OTCPK:CORZQ) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.

Core Scientific Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Core Scientific's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Core Scientific (Core Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Core Scientific Inc (OTCPK:CORZQ) » Definitions » Capex-to-Operating-Cash-Flow

Comparable Companies

BAND PRTH RXT LSAK CGNT OSPN LVOX BLZE REKR TCX MSFT ORCL ADBE PANW SNPS VMW FTNT CRWD PLTR SQ

Traded in Other Exchanges

CORZ:USA

Address

210 Barton Springs Road, Austin, TX, USA, 78704

Website

https://www.corescientific.com

Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. The business operates in two segments being; Equipment Sales and Hosting which consists of blockchain infrastructure, third-party hosting business and equipment sales to customers. Mining segment consists of digital asset mining for its account. The blockchain business generates revenue from the sale of consumption-based contracts and by providing hosting services. The digital asset mining segment earns revenue from operating a firm's owned computer equipment as part of a pool of users that process transactions conducted on one or more blockchain networks. In exchange, it receives digital currency assets.

Executives

Adam Taylor Sullivan	officer: President	C/O CORE SCIENTIFIC, INC., 2407 S. CONGRESS AVENUE, AUSTIN TX 78704
Darin Feinstein	director, 10 percent owner, officer: Chief Vision Officer	2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Sterling Denise Marie Brucia	officer: Chief Financial Officer	C/O CORE SCIENTIFIC, INC., 201 BARTON SPRINGS ROAD, AUSTIN TX 78704
Matt Minnis	director	2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Brian Neville	officer: Chief Accounting Officer	C/O CORE SCIENTIFIC, INC., 2800 NORTHROP WAY, BELLEVUE WA 98004
Todd M Duchene	officer: EVP, GC and Secretary	847 GIBRALTAR DR., MILPITAS CA 95035
Michael Trzupek	officer: Chief Financial Officer	2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Stacie Olivares	director	2525 E. CAMELBACK RD., STE 850, PHOENIX AZ 85016
Jarvis V. Hollingsworth	director	100 WEST HOUSTON STREET, SAN ANTONIO TX 78205
Michael J Levitt	director, officer: Chief Executive Officer	KAYNE ANDERSON CAPITAL ADVISORS, L.P., 1800 AVENUE OF THE STARS, 3RD FLOOR, LOS ANGELES CA 90067
Dr Kneeland Youngblood	director	C/O GAP, INC., 2 FOLSOM ST., SAN FRANCISCO CA 94105
John P Mcgarrity	officer: General Counsel and Secretary	321 N. CLARK STREET, CHICAGO IL 60054
Sullivan Colleen	director	420 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA 92037
Theodore J Brombach	10 percent owner	321 N. CLARK STREET, CHICAGO IL 60054
Patrick C Eilers	director, 10 percent owner, officer: Chief Executive Officer	THREE FIRST NATIONAL PLAZA STE 3800, CHICAGO IL 60602